Roche Global Launch NGS AVENIO Tumor Tissue Analysis Kits

 Roche Global Launch NGS AVENIO Tumor Tissue Analysis Kits

Roche Global Launch NGS AVENIO Tumor Tissue Analysis Kits

Shots:

  • Roche has launched three NGS AVENIO (next-generation sequencing) Tumor Tissue Analysis Kits as AVENIO Tumor Tissue Targeted Kit, Expanded Kit and Surveillance Kit for detecting all four mutation classes in solid tumors
  • AVENIO Tumor Tissue Analysis Kits: Targeted kit is a 17-gene comprehensive genomic profiling assay for identifying guideline-related biomarkers; Expanded Kit is a 77-gene comprehensive genomic profiling assay with both guideline-related and emerging biomarkers for genetic mutations; Surveillance Kit with 197 genes used for baselining variants in longitudinal tumor
  • NGS AVENIO Tumor Tissue Analysis Kits will be used for oncology research

Click here to read full press release/ article | Ref: Roche | Image: Biospectrum

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post